As they are currently developed, chatbots powered by artificial intelligence are not ready to be used as medical devices.
Commentary published in the journal
Commentary from an article in Nature explores the challenge to regulating chatbots as medical devices.
As they are currently developed, chatbots powered by artificial intelligence are not ready to be used as medical devices.
Commentary published in the journal
Apple and Synchron are teaming up to develop technologies that will one day allow people who can’t use their hands or voice to control iPhones, iPads and other Apple devices by using only their thoughts.
While the initial focus is medical devices and life sciences, Ketryx sees future opportunities in other high-regulation sectors including automotive, aerospace and defense, pharma manufacturing and nuclear systems.
After publishing encouraging results from first-in-human trials of its brain-computer interface, Axoft announced plans to sell its BCI-enabling material Fleuron to researchers and private organizations for R&D use. The company sees this as a revenue stream and feedback loop to refine its BCI platform designed for safer, longer-lasting brain implants.